Close X
Tuesday, December 3, 2024
ADVT 
International

Indian-origin Sikh on trial for $10.4mn crypto bungle in Melbourne

Darpan News Desk IANS, 11 Oct, 2022 04:49 PM
  • Indian-origin Sikh on trial for $10.4mn crypto bungle in Melbourne

Sydney, Oct 11 (IANS) An Indian-origin Sikh and his partner, who received $10.4 million from a cryptocurrency company by mistake, will face trial in Australia over allegations that they spent the money on items including a $1.2 million house.

Jatinder Singh, 37, and his partner, Thevamanogari Manivel, 40, appeared by video link from prison in Melbourne Magistrates Court on Tuesday, where they were committed to stand trial over theft and other charges, the Canberra Times reported.

Crypto.com intended to refund Manivel $100 but she was erroneously transferred $10,474,143. The company noticed its mistake when an audit was conducted in December 2021.

A subsequent probe found that an employee in Bulgaria, who processed the refund in May 2021, had incorrectly entered $10.4 million into an Excel spreadsheet.

Even though that Crypto.com account was in Singh's name, the transfer was sent to Manivel's account as he used her bank card to buy cryptocurrency, the Melbourne Magistrates Court was told.

Singh allegedly thought he won the money after being sent a notification from the Crypto.com app about a competition. This was also what he told Manivel, a Malaysian national.

Investigations have since revealed that $4 million of the money was allegedly transferred to an offshore bank account with other amounts spent on items including a $1.2 million home in Craigieburn and three other properties, a car, art, furniture and gifts to friends in Melbourne of more than $1 million each, a report in The Age said.

Manivel, presently out on bail, was arrested at Melbourne Airport in March 2022 while allegedly trying to fly home to Malaysia on a one-way ticket with about $11,000 in cash.

The couple will face directions hearing in the County Court on November 8.

MORE International ARTICLES

UK advises limiting AstraZeneca in under-30s amid clot worry

UK advises limiting AstraZeneca in under-30s amid clot worry
While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced" among younger people who are less likely to become seriously ill with COVID-19

UK advises limiting AstraZeneca in under-30s amid clot worry

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot